Please login to the form below

Not currently logged in
Email:
Password:

Bosulif

This page shows the latest Bosulif news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s leukaemia drug Mylotarg backed for use in EU

Pfizer’s leukaemia drug Mylotarg backed for use in EU

Kineret (anakinra) in rare inflammatory condition Still’s disease; and Pfizer’s Bosulif (bosutinib) as a treatment for newly-diagnosed Philadelphia chromosome-positive chronic myelogenous leukaemia (CML).

Latest news

More from news
Approximately 5 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Avillion names Allison Jeynes-Ellis CEO Avillion names Allison Jeynes-Ellis CEO

    candidates. She will now lead Avillion as it prepares to advance its first collaborative development agreement with Pfizer to conduct a global phase III clinical trial evaluating Bosulif (bosutinib) as a

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Playing Mind Games
To give a brief strong direction, we need to ascertain how the brand intends to win attention, how it will engage, what its call to action will be and how...
PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....

Infographics